Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Einstein Jr: Rivaroxaban in infants < 6 months with thrombosis
NCT02564718Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of rivaroxaban in arterial thrombosis, venous thrombosis, sponsored by Bayer. Started Nov 2015; status: completed.
02
Drugs
rivaroxaban
03
Conditions
arterial thrombosisvenous thrombosis
Beyond the preview
Go deeper on NCT02564718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02564718.